Diminished cardiac fibrosis in heart failure is associated with altered ventricular arrhythmia phenotype
- PMID: 20233273
- PMCID: PMC3703442
- DOI: 10.1111/j.1540-8167.2010.01736.x
Diminished cardiac fibrosis in heart failure is associated with altered ventricular arrhythmia phenotype
Abstract
Objectives: We sought to define the role of interstitial fibrosis in the proarrhythmic phenotype of failing ventricular myocardium.
Background: Multiple cellular events that occur during pathological remodeling of the failing ventricle are implicated in the genesis of ventricular tachycardia (VT), including interstitial fibrosis. Recent studies suggest that ventricular fibrosis is reversible, and current anti-remodeling therapies attenuate ventricular fibrosis. However, the role of interstitial fibrosis in the proarrhythmic phenotype of failing ventricular myocardium is currently not well defined.
Methods: Class II histone deacetylases (HDACs) have been implicated in promoting collagen biosynthesis. As these enzymes are inhibited by protein kinase D1 (PKD1), we studied mice with cardiomyocyte-specific transgenic over-expression of a constitutively active mutant of PKD1 (caPKD). caPKD mice were compared with animals in which cardiomyopathy was induced by severe thoracic aortic banding (sTAB). Hearts were analyzed by echocardiographic and electrocardiographic means. Interstitial fibrosis was assessed by histology and quantified biochemically. Ventricular arrhythmias were induced by closed-chest, intracardiac pacing.
Results: Similar degrees of hypertrophic growth, systolic dysfunction and mortality were observed in the two models. In sTAB mice, robust ventricular fibrosis was readily detected, but myocardial collagen content was significantly reduced in caPKD mice. As expected, VT was readily inducible by programmed stimulation in sTAB mice and VT was less inducible in caPKD mice. Surprisingly, episodes of VT manifested longer cycle lengths and longer duration in caPKD mice.
Conclusion: Attenuated ventricular fibrosis is associated with reduced VT inducibility, increased VT duration, and significantly longer arrhythmia cycle length.
© 2010 Wiley Periodicals, Inc.
Figures
References
-
- Hill JA, Olson EN. Cardiac plasticity. N Engl J Med. 2008;358:1370–1380. - PubMed
-
- Frey N, Olson EN. Cardiac hypertrophy: The good, the bad, and the ugly. Annu Rev Physiol. 2003;65:45–79. - PubMed
-
- Nass RD, Aiba T, Tomaselli GF, Akar FG. Mechanisms of disease: Ion channel remodeling in the failing ventricle. Nat Clin Pract Cardiovas Med. 2008;5:196–207. - PubMed
-
- Spinale FG. Myocardial matrix remodeling and the matrix metal-loproteinases: Influence on cardiac form and function. Physiol Rev. 2007;87:1285–1342. - PubMed
-
- Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res. 2004;95:754–763. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
